Iowa State Bank’s GSK GSK Stock Holding History

Iowa State Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,236	Closed	-$333K	–	124
2020 Q4	$333K	Sell	7,236 -1,576	-18%	-$72.4K	0.11%	99
2020 Q3	$415K	Buy	8,812 +1,656	+23%	+$83K	0.16%	84
2020 Q2	$365K	Sell	7,156 -6,018	-46%	-$309K	0.16%	85
2020 Q1	$624K	Sell	13,174 -1,686	-11%	-$89.9K	0.29%	73
2019 Q4	$873K	Sell	14,860 -1,794	-11%	-$99.8K	0.31%	72
2019 Q3	$889K	Sell	16,654 -15,693	-49%	-$807K	0.34%	70
2019 Q2	$1.62M	Buy	32,347 +576	+2%	+$28.9K	0.72%	47
2019 Q1	$1.66M	Buy	31,771 +1,513	+5%	+$75.6K	0.76%	47
2018 Q4	$1.45M	Sell	30,258 -481	-2%	-$23.7K	0.73%	46
2018 Q3	$1.54M	Buy	30,739 +808	+3%	+$41.1K	0.69%	48
2018 Q2	$1.51M	Sell	29,931 -72	-0.2%	-$3.63K	0.72%	46
2018 Q1	$1.47M	Sell	30,003 -256	-0.8%	-$11.9K	0.71%	47
2017 Q4	$1.34M	Sell	30,259 -7,569	-20%	-$350K	0.6%	48
2017 Q3	$1.92M	Sell	37,828 -466	-1%	-$23.6K	0.9%	39
2017 Q2	$2.06M	Sell	38,294 -184	-0.5%	-$9.81K	0.99%	40
2017 Q1	$2.03M	Buy	38,478 +4,144	+12%	+$210K	0.99%	40
2016 Q4	$1.65M	Sell	34,334 -2,015	-6%	-$99.5K	0.85%	40
2016 Q3	$1.96M	Buy	36,349 +2,424	+7%	+$133K	1.05%	39
2016 Q2	$1.84M	Buy	33,925 +1,484	+5%	+$78.2K	1%	39
2016 Q1	$1.64M	Buy	32,441 +572	+2%	+$28.5K	0.93%	42
2015 Q4	$1.61M	Buy	31,869 +1,709	+6%	+$87.1K	0.95%	42
2015 Q3	$1.45M	Buy	30,160 +740	+3%	+$38.5K	0.99%	41
2015 Q2	$1.53M	Buy	29,420 +1,644	+6%	+$92.6K	0.97%	44
2015 Q1	$1.6M	Buy	27,776 +2,240	+9%	+$128K	1.02%	42
2014 Q4	$1.36M	Sell	25,536 -1,346	-5%	-$75.3K	0.86%	45
2014 Q3	$1.54M	Buy	26,882 +757	+3%	+$46.4K	1.03%	42
2014 Q2	$1.75M	Buy	26,125 +724	+3%	+$49K	1.18%	39
2014 Q1	$1.7M	Buy	25,401 +2,016	+9%	+$136K	1.21%	39
2013 Q4	$1.56M	Buy	23,385 +1,157	+5%	+$75K	1.15%	40
2013 Q3	$1.39M	Buy	22,228 +3,344	+18%	+$215K	1.09%	39
2013 Q2	$1.18M	Buy	+18,884	New	+$1.2M	0.97%	44

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Iowa State Bank's GSK Position: Q1 2021 in Review

Iowa State Bank sold out of GSK (GSK) in Q1 2021, closing a stake of 7,236 shares — an estimated $333K sold.

Iowa State Bank first reported a position in GSK in Q2 2013 and held it in 31 quarters. The position peaked at $2.06M in Q2 2017. 775 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Iowa State Bank reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Iowa State Bank sold 7,236 GSK shares in Q1 2021, an estimated $333K.
Iowa State Bank first reported a position in GSK in Q2 2013 and held it in 31 quarters.
Iowa State Bank's GSK position peaked at $2.06M in Q2 2017.
775 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Iowa State Bank's 13F filing for Q1 2021, filed 15 Apr 2021.